Pharmaceutical manufacturer of treatments for rare and ultra-rare diseases.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2025 | ARNOLD & PORTER KAYE SCHOLER LLP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | ARNOLD & PORTER KAYE SCHOLER LLP |
4th Quarter (Oct 1 - Dec 31) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| ARNOLD & PORTER KAYE SCHOLER LLP | 3 | — |
| Issue | Activities |
|---|---|
| Health Issues | 3 |
| Trade (domestic/foreign) | 3 |
| Medicare/Medicaid | 3 |